3rd Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$510,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2017 (HR4909/S 2943) Department of Defense Appropriations Bill for 2017 (HR 5293/S 3000)

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5293 (114th), H.R. 4909 (114th)

Health Issues HCR

Legislative discussions related to issues of health care pricing, value and outcomes. Implementation issues related to the Pharmaceutical Quality, Security and Accountability Act (P.L. 113-54) Regulatory and legislative health care issues, including the 340B program HR6 - 21st Century Cures Act Senate Finance Committee Chronic Care Work Group Initiative Senate HELP Innovations Project Centers for Medicare and Medicaid Innovation demonstration programs

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th)

Medicare/Medicaid MMM

Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015 HR 5122 - To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. Revisions to Medicare reimbursement programs, including CMMI demonstration proposals

LobbyistCovered position, as disclosed
TIMOTHY CLARK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2404 (114th), H.R. 5122 (114th)

Budget/Appropriations BUD

Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products H Con Res 125/S Con Res 11 - Establishing the budget for the United States Government for FY 2017 and setting forth appropriate budgetary levels for FYs 2018 through 2026. H.R.5325 - Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S.Con.Res. 11 (114th), H.Con.Res. 125 (114th), H.R. 5325 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.